You're offline — showing cached data
B BibaMoneypowered by AI OS

Johnson & Johnson

JNJ · NYSE
Healthcare · Drug Manufacturers - General
Market cap
P/E (TTM)
Net margin
Revenue / share

About Johnson & Johnson

Johnson & Johnson (JNJ) is a multinational healthcare conglomerate that develops, manufactures, and sells a broad range of healthcare products worldwide. The company operates through two primary segments: Innovative Medicine, which focuses on prescription drugs in areas such as oncology, immunology, and neuroscience, and MedTech, which offers medical devices and solutions for surgery, orthopedics, and vision. Key products include the COVID-19 vaccine, cancer treatments like Darzalex, and consumer health brands such as Tylenol and Neutrogena.

Why it matters

Johnson & Johnson is one of the largest and most diversified healthcare companies globally, with a market capitalization exceeding $400 billion. Its dual focus on pharmaceuticals and medical devices provides a balanced revenue stream and resilience across economic cycles. The company's extensive R&D pipeline and established brand portfolio make it a bellwether for the healthcare sector, closely watched by investors for its consistent dividend growth and broad exposure to healthcare trends.

Company site ↗

How we research JNJ

Fundamentals like the ones above feed our fundamental screen — EPS acceleration, ROE and momentum∧quality — the one research class that survives walk-forward in our testing. We don’t issue price targets or buy/sell calls: see /edge for how rigorously (and how rarely) anything passes. This page is market data and research, not investment advice.

Data updated 00:00 UTC, 26 Jun 2026 · source: Financial Modeling Prep via AI OS.